Get started
Author

Matthew Trotta

Observed name: M. Trotta
ORCID: 0000-0003-3809-2492
Observed ORCID: 0000-0003-3809-2492
OpenAlex ID: A5082649522
MALT1 Protease Plays a Dual Role in the Allergic Response by Acting in Both Mast Cells and Endothelial Cells
2020 · Danielle N Alfano, Linda R Klei, et al. · The Journal of Immunology · 16
A small-molecule inhibitor of BCL10-MALT1 interaction abrogates progression of diffuse large B cell lymphoma
2025 · Heejae Kang, Lisa M. Maurer, et al. · Journal of Clinical Investigation · 7
PDF
Safety of Radiation Therapy in Patients With Prostate Cancer and Inflammatory Bowel Disease: A Systematic Review
2023 · Matthew Trotta, Krishnan R. Patel, et al. · Practical Radiation Oncology · 7
PDF
Blocking the Bcl10-malt1 Interaction in Diffuse Large B-cell Lymphoma
2022 · L. Maurer, H. Kang, et al. · Leukemia Research · 1
Cardiovascular Morbidity Following Definitive Chemoradiotherapy for Lung Cancer in an Appalachian Population
2026 · Vivian Salama, Joseph A. Schmidlen, et al. · Cancers
Cardiovascular Adverse Events After Definitive Chemoradiotherapy for Lung Cancer in an Appalachian Population: Incidence and Machine Learning-Based Prediction
2026 · Vivian Salama, Joseph A. Schmidlen, et al. · medRxiv
PDF
487 | MicroRNAs TARGET TUMOR SUPPRESSOR GRK2 IN MALT1‐DEPENDENT DIFFUSE LARGE B‐CELL LYMPHOMA
2025 · J. Cheng, M. Smyers, et al. · Hematological Oncology
PDF
GRK2, AN INHIBITOR OF MALT1-DEPEDENT ONCOGENIC SIGNALING, IS DOWNREGULATED BY microRNA IN ABC-DLBCL
2022 · J. Cheng, M. Smyers, et al. · Leukemia Research
Abstract PO-13: Structural requirements for GRK2-mediated inhibition of the MALT1 proto-oncoprotein
2020 · Lisa M. Maurer, Matthew Trotta, et al. · Blood Cancer Discovery
Works count: 9
Citation count: 31
H-index: 3
I10-index: 1
Year
Topic
Type